Who Is Responsible When a Medical Device Causes Harm in Louisiana?

The surgical mesh had been in place for four years. Then the revision surgery, and the pathology report that explained why everything hurt: the mesh had eroded through the surrounding tissue. The question that followed the diagnosis was the one that trips up most patients at this stage. Who exactly is responsible for this?

The answer under Louisiana law is almost never just one party. The Louisiana Products Liability Act, La. R.S. 9:2800.51 et seq., governs manufacturer liability. Louisiana Civil Code Article 2315 covers negligence by other defendants, including surgeons and hospitals. In a medical device case, you may have claims against several parties at once, and understanding who is responsible for what shapes the entire strategy of the case.

The Manufacturer: Three Types of Defect Claims Under the LPLA

The Louisiana Products Liability Act gives injured patients three distinct theories against a device manufacturer. You do not need all three to win. One valid defect type is enough, but experienced attorneys plead all that apply, because juries sometimes accept one theory after rejecting another.

A design defect claim argues that the product's design was unreasonably dangerous before a single unit was manufactured. Every device built to that blueprint shares the same flaw. The test in Louisiana is whether there was a reasonable alternative design that would have reduced or eliminated the danger without impairing the device's utility. If competing devices on the market in the same product category had a design that avoided the risk, that evidence is directly relevant.

A manufacturing defect claim argues that the specific unit implanted in your body deviated from the manufacturer's own design specifications. The blueprint was fine. This particular device was not built correctly. Lot numbers, batch records, and FDA MAUDE data showing other complaints from the same production run all feed into this theory.

A failure to warn claim argues that the manufacturer knew about risks it did not adequately disclose to surgeons or patients. The learned intermediary doctrine in Louisiana means manufacturers typically discharge their warning duty by adequately informing the implanting physician, not necessarily the patient directly. But if the manufacturer's surgeon training materials, product inserts, or required labeling omitted or downplayed a known risk, that failure is actionable even if the FDA cleared the device.

Distributors and Sellers: The Middle of the Chain

Between the manufacturer and the operating room sits a distribution chain. Medical device distributors negotiate hospital supply contracts. Sales representatives are often present in the OR during implant procedures, advising surgeons on technique. These parties can carry their own liability under Louisiana law.

We explain how fault percentages and deadlines work after a Louisiana injury in our 2026 Tort Reform Survival Guide.

A distributor who sold a device while knowing about a design problem or an active recall may be liable under Article 2315 negligence, even if the LPLA's strict liability framework does not reach them as directly as it does the manufacturer. A sales representative who gave the surgeon incorrect sizing advice during the procedure may have committed an act of negligence independent of any product defect claim.

Distributors and their representatives also hold documentation the manufacturer may not have. Their call logs, surgeon visit notes, device tracking records, and internal communications about product complaints are discoverable and often very revealing.

In Louisiana, dealers and sellers of used or reconditioned medical equipment can also carry liability if they placed a defective product into the stream of commerce without adequate inspection. This is less common with implants than with capital equipment like imaging machines or surgical robots, but the theory exists.

The Implanting Surgeon and the Hospital

A defective device claim and a medical malpractice claim are two different legal animals, but they often live in the same case. A surgeon who implants a device using poor technique, selects the wrong size for the patient's anatomy, or fails to disclose known risks of the specific device is potentially liable for malpractice separate from anything the manufacturer did.

Louisiana medical malpractice is governed by La. R.S. 40:1231.1 et seq., the Medical Malpractice Act. Before you can file a malpractice suit against a qualified healthcare provider, you must present the claim to a Medical Review Panel. That panel is composed of three physicians and an attorney chairman. The process typically takes twelve to twenty-four months. While the panel is pending, prescription on the underlying claim is suspended.

Hospitals have their own liability exposure. A hospital that allowed a device to be implanted despite an active recall notice from the manufacturer, or that failed to train staff on proper device handling and storage, may be independently negligent under Article 2315. So can a hospital that returned the explanted device to the manufacturer before the patient had an opportunity to preserve it.

Keep CHRISTUS Ochsner Lake Area Hospital and Lake Charles Memorial Hospital in mind as the primary facilities in the area where these procedures happen. The surgical center's own policies and credentialing records for the implanting surgeon may become relevant in litigation.

FDA Approval as a Potential Shield — and Its Limits

Manufacturers routinely argue that FDA clearance or approval means they did everything right and state law claims are preempted. That defense works in some circumstances and fails in others. Knowing the difference matters.

Devices that went through the FDA's Premarket Approval process received a device-specific authorization based on a clinical data submission. Congress has expressed a desire to keep state law requirements from conflicting with PMA conditions. Courts have held that some state law claims against PMA devices are preempted where those claims would impose requirements different from what the FDA approved.

But many implants reach the market through 510(k) clearance, which does not require clinical data and is not device-specific approval. It is a determination that the device is substantially equivalent to a prior device. Courts have consistently held that 510(k) clearance does not preempt state law LPLA claims. A device that cleared as substantially equivalent to a 1985 predicate device and then failed in your body is not shielded by that clearance.

Even for PMA devices, state law claims that parallel federal requirements, rather than imposing additional requirements, are generally not preempted. This is a technical analysis that requires an attorney familiar with both federal device regulation and Louisiana products liability law.

How Louisiana's 51% Fault Rule Applies Across Multiple Defendants

Louisiana's modified comparative fault rule under Civil Code Article 2323 assigns fault percentages to every party whose conduct contributed to an injury, including the plaintiff. Under the 2026 rule, a plaintiff who is found more than 50% at fault collects nothing. Below that bar, recovery is reduced by the plaintiff's percentage.

In a multi-defendant device case, fault is allocated across all parties. A jury might find the manufacturer 50% at fault for a design defect, the surgeon 30% at fault for poor implant technique, and the plaintiff 20% at fault for ignoring post-operative weight restrictions. The plaintiff collects from both defendants, reduced by their own 20%. On a $500,000 verdict, that means the patient nets $400,000 total, collected from the manufacturer and the surgeon in proportion to their fault shares.

The 20% fault reduction is $100,000. That is a real number. And it could easily be 35% or 45% if the patient's record shows more violations of post-op instructions, missed appointments, or failure to report symptoms. Documentation of compliance is not a minor administrative task. It is directly linked to how much money you actually collect.

Defendants also point fingers at each other. The manufacturer will argue the surgeon caused the failure by improper technique. The surgeon will argue the device was defective regardless of technique. Having all parties as defendants and letting them litigate each other's fault percentages can actually work in the plaintiff's favor, because neither defendant wants to appear fully responsible to the jury.

Frequently Asked Questions

Can I sue both the manufacturer and my surgeon at the same time?

Yes. Product defect claims under the LPLA and medical malpractice claims under the Medical Malpractice Act are separate legal actions, but they can be pursued simultaneously. The malpractice claim requires a Medical Review Panel first, which takes time. An attorney will typically file the LPLA claim in district court and pursue the MRP process in parallel so both actions move forward together.

What if the manufacturer is based overseas or no longer in business?

Foreign manufacturers that sell into Louisiana markets can be sued in Louisiana courts if they have sufficient contacts with the state. Defunct companies may have successor corporations that inherited liability, or there may be insurance policies that remain available even after the company closed. A good attorney will trace the corporate history. If the manufacturer truly has no assets and no successor, the distributor and other parties in the chain of commerce become the primary defendants.

How does the failure to warn theory work if my surgeon knew about the risk?

Louisiana follows the learned intermediary doctrine: if the manufacturer gave adequate warnings to the implanting physician, the manufacturer's duty to warn the patient is generally satisfied. But if the manufacturer's warning to the surgeon was itself inadequate or inaccurate, that defense fails. Internal company documents showing the manufacturer downplayed a known risk in surgeon training materials are the most powerful evidence in failure-to-warn cases.

Does the manufacturer have to pay my attorney fees?

Louisiana does not have a fee-shifting statute for LPLA claims, so attorney fees are generally not recoverable from the manufacturer as part of a judgment. Most device injury attorneys work on contingency, meaning they receive a percentage of the recovery if the case settles or goes to verdict, and nothing if it does not. That arrangement lets injured patients pursue legitimate cases without upfront legal costs.

Is there a class action for my device, and should I join it?

For some widely distributed defective devices, federal multi-district litigation or class actions exist. Joining an MDL or class can be efficient but often results in lower individual payouts than pursuing an individual case. Whether that tradeoff makes sense depends on the severity of your injuries, the strength of your individual facts, and the current status of the litigation. An attorney familiar with the specific device and any existing litigation can walk you through the decision.

Legal Disclaimer: This article is for general information only and is not legal advice. Louisiana medical device and products liability law has a lot of moving parts, and the facts of every case are different. Statutes, regulations, and case law also change over time. Reading this does not create an attorney-client relationship. If you were injured by a defective medical device or implant in Lake Charles or Calcasieu Parish, talk to a licensed Louisiana personal injury attorney as soon as you can. The one-year prescriptive period for personal injury claims is strictly enforced.